AbbVie (ABBV) Shares Outstanding (Weighted Average) (2012 - 2026)

AbbVie (ABBV) has 15 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) changed 0.11% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (changed 0.11% YoY) and the FY2025 annual result came in at $1.8 billion, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) steadied at $1.8 billion in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $1.8 billion in Q1 2022 and bottomed at $1.8 billion in Q2 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.8 billion (2024), against an average of $1.8 billion.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) retreated 0.17%; it then gained 0.11% in 2026.
• Tracing ABBV's Shares Outstanding (Weighted Average) over 5 years: stood at $1.8 billion in 2022, then retreated by 0.17% to $1.8 billion in 2023, then increased by 0.06% to $1.8 billion in 2024, then changed by 0.0% to $1.8 billion in 2025, then climbed by 0.06% to $1.8 billion in 2026.
• Per Business Quant, the three latest ABBV Shares Outstanding (Weighted Average) figures stand at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025).

Peer Comparison